217 related articles for article (PubMed ID: 23542354)
1. A systematic quantitative proteomic examination of multidrug resistance in Acinetobacter baumannii.
Chopra S; Ramkissoon K; Anderson DC
J Proteomics; 2013 Jun; 84():17-39. PubMed ID: 23542354
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of outer membrane vesicles proteomics and whole-cell transcriptome analysis of eravacycline induced Acinetobacter baumannii strains.
Kesavan D; Vasudevan A; Wu L; Chen J; Su Z; Wang S; Xu H
BMC Microbiol; 2020 Feb; 20(1):31. PubMed ID: 32046644
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii.
Yun SH; Choi CW; Kwon SO; Park GW; Cho K; Kwon KH; Kim JY; Yoo JS; Lee JC; Choi JS; Kim S; Kim SI
J Proteome Res; 2011 Feb; 10(2):459-69. PubMed ID: 21053951
[TBL] [Abstract][Full Text] [Related]
4. Variable spontaneous mutation rate in clinical strains of multidrug-resistant Acinetobacter baumannii and differentially expressed proteins in a hypermutator strain.
Karami-Zarandi M; Douraghi M; Vaziri B; Adibhesami H; Rahbar M; Yaseri M
Mutat Res; 2017 Aug; 800-802():37-45. PubMed ID: 28646746
[TBL] [Abstract][Full Text] [Related]
5. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
[TBL] [Abstract][Full Text] [Related]
6. iTRAQ-Based Differential Proteomic Analysis Reveals the Pathways Associated with Tigecycline Resistance in Acinetobacter baumannii.
Yang N; Liu Y; He P; Ke R; Zhao Y; Feng Y; Jing R; Ma S; Liu C; Geng Y; Wu X; Wei Y
Cell Physiol Biochem; 2018; 51(3):1327-1339. PubMed ID: 30481750
[TBL] [Abstract][Full Text] [Related]
7. Insights into the Periplasmic Proteins of
Scribano D; Marzano V; Levi Mortera S; Sarshar M; Vernocchi P; Zagaglia C; Putignani L; Palamara AT; Ambrosi C
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337077
[TBL] [Abstract][Full Text] [Related]
8. Proteogenomic characterization of antimicrobial resistance in extensively drug-resistant Acinetobacter baumannii DU202.
Lee SY; Yun SH; Lee YG; Choi CW; Leem SH; Park EC; Kim GH; Lee JC; Kim SI
J Antimicrob Chemother; 2014 Jun; 69(6):1483-91. PubMed ID: 24486871
[TBL] [Abstract][Full Text] [Related]
9. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of outer membrane proteins from Acinetobacter baumannii DU202 in tetracycline stress condition.
Yun SH; Choi CW; Park SH; Lee JC; Leem SH; Choi JS; Kim S; Kim SI
J Microbiol; 2008 Dec; 46(6):720-7. PubMed ID: 19107403
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
12. Genomic characterization of extensively drug-resistant Acinetobacter baumannii strain, KAB03 belonging to ST451 from Korea.
Lee SY; Oh MH; Yun SH; Choi CW; Park EC; Song HS; Lee H; Yi YS; Shin J; Chung C; Moon JY; Lee JC; Kim GH; Kim SI
Infect Genet Evol; 2018 Nov; 65():150-158. PubMed ID: 30053642
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
[TBL] [Abstract][Full Text] [Related]
14. Tn2008-driven carbapenem resistance in Acinetobacter baumannii isolates from a period of increased incidence of infections in a Southwest Virginia hospital (USA).
Rao J; Susanti D; Childress JC; Mitkos MC; Brima JK; Baffoe-Bonnie AW; Pearce SN; Grgurich D; Fernandez-Cotarelo MJ; Kerkering TM; Mukhopadhyay B
J Glob Antimicrob Resist; 2018 Mar; 12():79-87. PubMed ID: 28899807
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain.
Tiwari V; Vashistt J; Kapil A; Moganty RR
PLoS One; 2012; 7(6):e39451. PubMed ID: 22761799
[TBL] [Abstract][Full Text] [Related]
16. Complete genome sequence and genome-scale metabolic modelling of Acinetobacter baumannii type strain ATCC 19606.
Zhu Y; Lu J; Zhao J; Zhang X; Yu HH; Velkov T; Li J
Int J Med Microbiol; 2020 Apr; 310(3):151412. PubMed ID: 32081464
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals.
Ibrahim S; Al-Saryi N; Al-Kadmy IMS; Aziz SN
Mol Biol Rep; 2021 Oct; 48(10):6987-6998. PubMed ID: 34460060
[TBL] [Abstract][Full Text] [Related]
18. iTRAQ-Based Quantitative Proteomic Analysis of Acinetobacter baumannii under Hypoxia and Normoxia Reveals the Role of OmpW as a Virulence Factor.
Gil-Marqués ML; Pachón J; Smani Y
Microbiol Spectr; 2022 Apr; 10(2):e0232821. PubMed ID: 35234505
[TBL] [Abstract][Full Text] [Related]
19. Comparative proteomics analyses of Acinetobacter baumannii strains ATCC 17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance.
Elhosseiny NM; Elhezawy NB; Attia AS
Microb Pathog; 2019 Mar; 128():20-27. PubMed ID: 30578836
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and molecular characterisations of carbapenem-resistant
Simo Tchuinte PL; Rabenandrasana MAN; Kowalewicz C; Andrianoelina VH; Rakotondrasoa A; Andrianirina ZZ; Enouf V; Ratsima EH; Randrianirina F; Collard JM
Antimicrob Resist Infect Control; 2019; 8():31. PubMed ID: 30792853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
